Dynamiker Biotechnology, founded in March of 2014, is a high-tech enterprise integrated with R&D, production and sales globally. It focuses on developing early and rapid in-vitro diagnostics of invasive fungal diseases (IFD). Headquarters is located at Tianjin. R&D Team: By adhering to the principle of “Technology is Power”，the R&D team is consisted of domestic and overseas talented experts specialized in IVD, microbiology, immunology, molecular biology and clinical chemistry. Dr. Zeqi Zhou, as CTO of the team, obtained Ph.D. from Ohio University and Postdoc at Harvard Medical School. With the extensive experience gained at Bayer and Wyeth, he led the R&D team successfully have developed over 20 novel products for early diagnosis of IFD, which have shown strong competitiveness in global market. Market Opportunity: The goal of Dynamiker is to “shape company’s brand with high quality and penetrate world’s market with innovation”. The products are CFDA-cleared, CE-marked and registered in Turkey, India, Pakistan, Georgia, Egypt, Brazil, Mexico, Columbia etc. Those products have already launched into more than 480 hospitals domestically and over 30 hospitals globally. Customer Service: High quality is essential for market development and customer satisfaction. Dynamiker focuses on the needs of clients and continuously improves quality of after-sales service. Four level after-sales service support system has been established, including clinical centers, distributor's technical support team, Dynamiker's customer service team and the R&D team. That greatly makes us achieve our customers' trust and support. Our Vision Looking ahead, all of us are full of both confidence and dynamics. Dynamiker keeps upholding our enterprise spirit: “Unity, Practicability, Openness and Innovation". We are working together to make our company as a global l leader in IFD-IVD field, create an innovative international brand and have our IPO launched by 2020.